Aaipharma Inactive 10-Q2004 Q2 Quarterly report

Filed: 9 Aug 04, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. sophomore Avg

New words: AAII, applied, approach, approaching, Arizona, back, begun, bond, book, breakeven, budgeting, ceased, chain, chemical, closure, comparison, competitor, counterclaim, cumulative, cured, David, dedicate, delivery, Disposal, divested, divestiture, draft, driven, enable, environment, eroded, erosion, Europe, evidencing, examination, Exit, experience, forecasting, franchise, front, gastrointestinal, hand, hotel, Hurley, incremental, inhibitor, intensive, interact, Jersey, Key, maintain, maturity, medical, Minimal, mitigate, NDA, notification, pharmacological, Phase, pipeline, platform, policy, prepay, program, promissory, proton, pump, punitive, receipt, recourse, recover, redirected, reserve, resolve, retail, retraining, reverted, sector, shelf, stabilize, sterile, strong, symbol, team, ticker, turn, utilization, utilized, viable, withheld

Removed: analytical, annually, azasan, corporation, covering, criteria, entering, hedged, identical, important, instrument, maintenance, matched, outsourced, Pediatric, perfectly, portfolio, positive, quantity, small, specialty, twelve

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Aaipharma similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION

The undersigned officers of the registrant certify that, to their knowledge, the quarterly report on Form 10-Q for the period ended June 30, 2004 fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 780(d)), and that information contained in this report fairly presents, in all material respects, the financial condition and results of operation of the registrant as of the dates and for the periods expressed in the report.


Date: August 9, 2004		/s/ Frederick D. Sancilio

		Frederick D. Sancilio, Ph.D.
		Executive Chairman and Chief Executive Officer

Date: August 9, 2004		/s/ Gina Gutzeit

		Gina Gutzeit
		Interim Chief Financial Officer